ComplianceFeaturesLegal FTC and FDA Issue Warnings to CBD Marketers May 1, 2019 By Ginny Pasqualone In a rare joint sanctions effort, regulators crack down on product claims, just as cannabidiol products take off. Please log in (or register) to continue viewing this content. Username or E-mail Password Remember Me Forgot Password cannabidoilcbdFarm BillFDAFTCGinny PasqualoneKelly Dryeregulation 0 comment 0 Facebook Twitter Google + Pinterest previous post Do Non-Compete and Non-Solicitation Clauses Hold Up in Court? next post Segmenting the Salesforce Related Articles Serious Business: The FTC’s Re-Deployment of the Penalty... September 1, 2021 Public Company CEOs Share Updates April 1, 2019 “Medical Marketing” Under Scrutiny October 2, 2018 FTC Announces Enforcement Actions Against AdvoCare November 1, 2019 LOOK FOR OUR JUNE ISSUE IN YOUR MAILBOX.... June 1, 2021 The PRO Act: Bad for Direct Selling April 1, 2021 Could Direct Selling be the Next #MeToo Controversy? September 6, 2018 How Pending Legislation Could Affect Your Company’s Compliance... September 1, 2021 Neora to Resume Case Against FTC in Texas October 1, 2020 Inclusive Diversity: What Does It Mean for Direct... July 1, 2020
